MiniMed Group, Inc.
MMED
Positions held
Your positionsMMED isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- MiniMed Group, Inc. is positioned in the growing healthcare sector, specifically in medical instruments and supplies, which benefits from increasing demand for innovative healthcare solutions.
- The company's revenue increased by 1% in the last quarter, reaching $843 million, compared to $837 million in the previous quarter.
- The operating margin expanded to 0.2%, indicating a potential turnaround in operational efficiency.
- Despite the growth potential, MiniMed Group faces challenges with a negative profit margin of approximately -9.7%, which raises concerns about profitability.
- The company reported a net income loss of $333 million for the year 2026, highlighting ongoing financial struggles.
- The debt-to-equity ratio stands at 1.63, suggesting a reliance on debt financing that could pose risks in a volatile market.
Fundamentals
| Market cap | $5.57B | Enterprise value | $5.42B | Trailing P/E | — | Forward P/E | 31.07 |
| PEG | — | Price / book | 1.54 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 16.6% | Earnings growth | — | Gross margin | 56.9% | Operating margin | 0.5% |
| Profit margin | -9.7% | ROE | -8.7% | ROA | — | Debt / equity | 0.02 |
| Current ratio | 1.81 | Free cash flow | — | Analyst recommendation | buy | Mean target | $24.85 |
| 52w high | $24.43 | 52w low | $10.65 |
Quarterly
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|---|
| Revenue | $843M | $837M | $790M | $752M | $723M | — |
| Op margin | 0.2% | -10.4% | -11.8% | -1.3% | 0.4% | — |
| Net income | $0.0M | -$185M | -$119M | -$27.0M | -$19.0M | — |
| Gross margin | 55.2% | 57.3% | 45.8% | 56.9% | 56.6% | — |
| Gross profit | $465M | $480M | $362M | $428M | $409M | — |
| Operating income | $2.0M | -$87.0M | -$93.0M | -$10.0M | $3.0M | — |
- Revenue +1% vs prior quarter ($843M vs $837M).
- Gross margin 55.2% (was 57.3% prior quarter).
- Operating margin expanded to 0.2%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | $3.1B | $2.7B | $2.5B | $2.2B |
| Op margin | -5.1% | 1.2% | -2.5% | -3.1% |
| Net income | -$333M | -$213M | -$112M | -$96.0M |
| Gross margin | 54.2% | 56.3% | 58.2% | 58.3% |
| Gross profit | $1.7B | $1.5B | $1.4B | $1.3B |
| Operating income | -$159M | $33.0M | -$61.0M | -$69.0M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.
2026-10-07 · Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
2026-10-06 · If The MiniMed Split-Off Stalls, What Happens To Your Medtronic Stock?
2026-10-05 · Responding more frequently to MiniMed Smart MDI alerts linked to better glucose outcomes for people with diabetes
2026-10-02 · Why Medtronic’s $4 Billion MiniMed Exchange Offer Is Losing Its Allure
2026-10-02 · DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
2026-09-28 · MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
2026-09-24 · Truist Initiates MiniMed Group at Buy With $29 Price Target
2026-09-22 · MiniMed (MMED): Nine Analysts Raised Targets, But Cash Flow Still Has a Catch
2026-09-14 · MiniMed Files S-4 as Medtronic Seeks to Exit Remaining Stake
2026-09-14 · MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
2026-09-14 · Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Price (daily)
Full chart · RSI · MACD · patterns